Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.37 |
| ▸ | RAB9A | P51151 | 3/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.37 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.37 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | CES2 | O00748 | 2/20 | 0.35 |
| ▸ | CES1 | P23141 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL72683 | 1.00 | TDP1 (0.42) | TDP1ALDH1A1LMNASRD5A2CA2 | |
| SCHEMBL27955132 | 1.00 | TDP1 (0.42) | TDP1ALDH1A1LMNASRD5A2CA2 | |
| SCHEMBL72172 | 1.00 | TDP1 (0.42) | TDP1ALDH1A1LMNASRD5A2CA2 | |
| SCHEMBL5461407 | 1.00 | TDP1 (0.42) | TDP1ALDH1A1LMNASRD5A2CA2 | |
| SCHEMBL6532888 | 1.00 | TDP1 (0.42) | TDP1ALDH1A1LMNASRD5A2CA2 | |
| SCHEMBL88252 | 1.00 | TDP1 (0.42) | TDP1ALDH1A1LMNASRD5A2CA2 | |
| SCHEMBL7348978 | 0.99 | TDP1 (0.41) | TDP1ALDH1A1LMNASRD5A2CA2 | |
| SCHEMBL7355024 | 0.99 | TDP1 (0.41) | TDP1ALDH1A1LMNASRD5A2CA2 | |
| Water SCHEMBL3859938 | 0.99 | TDP1 (0.41) | TDP1ALDH1A1LMNASRD5A2CA2 | |
| Water SCHEMBL1322825 | 0.99 | TDP1 (0.41) | TDP1ALDH1A1LMNASRD5A2CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070032535-A1 | Diastereomeric dynamic kinetic resolution process for preparing (+)-(2s,3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol, salts, and solvates thereof | Smith Kline Beecham Corporation D/b/a Glaxo Smith Kline (US) | 2007-02-08 | — | — | US | claimed |
| US-20060058300-A1 | Intermediates of bupropion metabolites synthesis | SEPRACOR INC. | 2006-03-16 | — | — | US | claimed |
| US-7781427-B2 | Process for preparing quinoline compounds and products obtained therefrom | WYETH LLC (US) | 2010-08-24 | — | — | US | disclosed |
| US-20100196714-A1 | PROCESS FOR PREPARING QUINOLINE COMPOUNDS AND PRODUCTS OBTAINED THEREFROM | WYETH (US) | 2010-08-05 | — | — | US | disclosed |
| US-20080281096-A1 | Resolution Process For Preparing (+)-2S,3S)-2-(3-Chlorophenyl)-3,3,3-Trimethyl-2-Morpholinol | HARRIS MICHAEL ANTHONY | 2008-11-13 | — | — | US | disclosed |
| EP-1807428-A2 | PROCESS FOR PREPARING QUINOLINE COMPOUNDS AND PRODUCTS OBTAINED THEREFROM | Wyeth (US) | 2007-07-18 | — | — | EP | disclosed |
| US-20070032535-A1 | Diastereomeric dynamic kinetic resolution process for preparing (+)-(2s,3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol, salts, and solvates thereof | Smith Kline Beecham Corporation D/b/a Glaxo Smith Kline (US) | 2007-02-08 | — | — | US | disclosed |
| EP-1678151-A1 | DIASTEREOMERIC DYNAMIC KINETIC RESOLUTION PROCESS FOR PREPARING (+)-(2S, 3S)-2-(3-CHLOROPHENYL)-3,5,5-TRIMETHYL-2-MORPHOLINOL, SALTS, AND SOLVATES THEREOF | SMITHKLINE BEECHAM CORPORATION (US) | 2006-07-12 | — | — | EP | disclosed |
| US-20060122385-A1 | Process for preparing quinoline compounds and products obtained therefrom | WYETH (US) | 2006-06-08 | — | — | US | disclosed |
| WO-2006052768-A2 | PROCESS FOR PREPARING QUINOLINE COMPOUNDS AND PRODUCTS OBTAINED THEREFROM | WYETH (US) | 2006-05-18 | — | — | WO | disclosed |
| WO-2005044809-A1 | DIASTEREOMERIC DYNAMIC KINETIC RESOLUTION PROCESS FOR PREPARING (+)-(2S, 3S)-2-(3-CHLOROPHENYL)-3,5,5-TRIMETHYL-2-MORPHOLINOL, SALTS, AND SOLVATES THEREOF | SMITHKLINE BEECHAM CORPORATION (US) | 2005-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060058300-A1 | Intermediates of bupropion metabolites synthesis | MAOB, MAOA, SLC18A2 | TDP1 456/4885ALDH1A1 266/4885LMNA 3466/4885 |
| US-20080281096-A1 | Resolution Process For Preparing (+)-2S,3S)-2-(3-Chlorophenyl)-3,3,3-Trimethyl-2-Morpholinol | TPMT, MTAP, METTL3 | TDP1 2228/4885ALDH1A1 3468/4885LMNA 2155/4885 |
| US-20070032535-A1 | Diastereomeric dynamic kinetic resolution process for preparing (+)-(2s,3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol, salts, and solvates thereof | METTL3, TPMT, MTAP | TDP1 1909/4885ALDH1A1 2670/4885LMNA 2821/4885 |
| US-20060122385-A1 | Process for preparing quinoline compounds and products obtained therefrom | NNMT, QTRT1, HNMT | TDP1 1424/4885ALDH1A1 1820/4885LMNA 1434/4885 |
| US-20100196714-A1 | PROCESS FOR PREPARING QUINOLINE COMPOUNDS AND PRODUCTS OBTAINED THEREFROM | NNMT, QTRT1, HNMT | TDP1 1424/4885ALDH1A1 1820/4885LMNA 1434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.